bpc-157 gut-brain axis support Delayed bpc-157 safety data humans BPC-157

Secondly, the systemic NAD + metabolome is largely unexplored

By weeks 5 through 8, more substantial structural changes emerge tissue resilience improves, stiffness decreases, and strength recovery accelerates

S., Tahamtani, Y

Musculoskeletal improvements in strength, range of motion, and pain reduction typically follow over weeks 3 through 6

NSAIDs and Gastric Mucosa Damage Inhibition of prostaglandin synthesis leading to mucosal damage Increased risk of gastric ulcers and bleeding Potential for black stools due to gastrointestinal bleeding Anticoagulants and Bleeding Risk Anticoagulants help prevent blood clots but raise the risk of bleeding

This shift requires the IID of eVP35 to rotate ~6.5 to align with mVP35 IID (Fig